Neuilly, France

Jacques Bure


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jacques Bure

Introduction

Jacques Bure, an accomplished inventor based in Neuilly, France, is known for his significant contributions to medicinal chemistry. With a focus on developing compounds that address inflammatory processes and painful syndromes, Bure's work has the potential to greatly impact the medical field.

Latest Patents

Bure holds a patent for "1-Methyl-4-piperidinol esters of 4-quinolinylamino benzoates." This innovative compound is designed with the formula wherein R can be 7-chloro-4-quinolyl, 7-trifluoromethyl-4-quinolyl, or 8-trifluoromethyl-4-quinolyl. These compounds and their physiologically tolerable acid addition salts are essential as they can be utilized as medicines, particularly in treating various inflammatory conditions.

Career Highlights

Jacques Bure has made a significant mark in the pharmaceutical sciences through his affiliation with Science Union Et Cie, a French medical research company. His pioneering work in the synthesis of medicinal compounds has set a foundation for future pharmaceutical advancements and treatments.

Collaborations

Throughout his career, Bure has collaborated with noted professionals such as Laszlo Beregi and Pierre Hugon. These partnerships have enhanced his research productivity and expanded the horizons of his innovations within the scientific community.

Conclusion

Jacques Bure's dedication to the development of medicines through his innovative patent showcases the vital role of inventors in the evolution of healthcare solutions. His ongoing contributions to medicinal chemistry not only demonstrate his expertise but also emphasize the importance of collaboration in achieving groundbreaking results.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…